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768Neutrophil-lymphocyte ratio as a predictor of
cognitive dysfunction in carotid endarterectomy
patients
Hadi J. Halazun, MD,a Joanna L. Mergeche, BA,b Kaitlin A. Mallon, BA,b E. Sander Connolly, MD,c,d and
Eric J. Heyer, MD, PhD,b,c New York, NY
Background: Systemic inﬂammation has been implicated in the development of cognitive dysfunction following carotid
endarterectomy (CEA). Neutrophil-lymphocyte ratio (NLR) is a reliable measure of systemic inﬂammation. We
hypothesize that patients with elevated preoperative NLR have increased risk of cognitive dysfunction 1 day after CEA.
Methods: Five hundred ﬁfty-one patients scheduled for CEA were enrolled at Columbia University in New York, NY from
1995 to 2012. NLR was retrospectively reviewed; only 432 patients had preoperative NLR values available within
2 weeks of CEA. NLR was analyzed as a continuous variable and categorically with a cutoff of $5 and <5 and equal
tertiles, as done in previous studies.
Results: Patients with cognitive dysfunction had signiﬁcantly higher NLR than those without cognitive dysfunction
(4.5 6 4.0 vs 3.2 6 2.6; P < .001). The incidence of cognitive dysfunction was signiﬁcantly higher in patients with NLR
$5 than NLR <5 (34.7% vs 12.8%; P < .001). Signiﬁcantly fewer patients in the low tertile had cognitive dysfunction than
in the high tertile (6.9% vs 25.9%; P <.001) and middle tertile (6.9% vs 17.4%; P[ .006). In the ﬁnal multivariate model,
diabetes mellitus (odds ratio [OR], 2.03; 95% conﬁdence interval [CI], 1.08-3.75; P[ .03) and NLR$5 (OR, 3.38; 95%
CI, 1.81-6.27; P < .001) were signiﬁcantly associated with higher odds of cognitive dysfunction, while statin use was
signiﬁcantly associated with lower odds (OR, 0.48; 95% CI, 0.27-0.84; P [ .01).
Conclusions: Preoperative NLR is associated with cognitive dysfunction 1 day after CEA. NLR $5 and diabetes mellitus
are signiﬁcantly associated with increased odds of cognitive dysfunction whereas statin use is signiﬁcantly associated with
decreased odds. (J Vasc Surg 2014;59:768-73.)Carotid endarterectomy (CEA) reduces the risk of
stroke in patients with signiﬁcant carotid artery stenosis.
Although the incidence of stroke during the perioperative
period of CEA is 3%-5%, a subtler form of neurologic
injury, cognitive dysfunction, is exhibited in approximately
25% of patients 1 day after CEA.1,2 Cognitive dysfunction
has been associated with markers of brain injury3 and
earlier retirement and mortality.4 While the underlying
cause of the cognitive dysfunction is likely multifactorial,
previous studies suggest that systemic inﬂammation plays
an important role.5-9 Systemic inﬂammation has been
implicated in the progression of atherosclerosis and plaque
instability.10 Genetic mutations linked to systemic inﬂam-
mation11,12 and elevated inﬂammatory markers like mono-
cyte count6 and monocyte chemoattractant protein13 are
signiﬁcantly associated with cognitive dysfunction after
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://dx.doi.org/10.1016/j.jvs.2013.08.095The neutrophil-lymphocyte ratio (NLR) is a readily
available marker of systemic inﬂammation. This ratio is
emerging as a robust predictor of deleterious outcomes
in many disciplines including, but not limited to, cancer
treatment,14-17 coronary intervention,18 coronary artery
bypass-grafting,19 and Alzheimer’s disease.20 Some epide-
miologic studies show that NLR could actually be a better
predictor of coronary syndrome than any other white
blood cell count subtype.21,22 A 2011 study found that
preoperative NLR can identify patients at increased risk
of death within 2 years of major vascular surgery and sug-
gested that it could be used as a preventative measure for
high-risk patients.14
NLR has not been directly studied in a population of
CEA patients nor has it been investigated for its predict-
ability of cognitive dysfunction. We hypothesize that
patients with elevated preoperative NLR have increased
risk of cognitive dysfunction 1 day after CEA.METHODS
Patients. Five hundred ﬁfty-one (551) CEA patients
were initially enrolled with written informed consent in an
Institutional Review Board-approved observational single
center study at Columbia University Medical Center in
New York, NY from 1995 to 2012 (http://www.
ClinicalTrials.gov NCT00597883). Eligible patients were
scheduled for elective CEA for high-grade carotid artery
stenosis (both symptomatic and asymptomatic), English-
speaking, and with no axis-I psychiatric disorders.
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patients had NLR values obtained 2 weeks before CEA and
were the only patients included in this analysis.
Anesthesia and surgery. All patients received general
anesthesia with standard hemodynamic and temperature
monitoring, as previously described.1 None received
blood transfusions. The surgical technique and anesthetic
management are repeated here.1,23,24 A shunt was available
in all cases should electroencephalographic (EEG) changes
reﬂect cerebral ischemia; however, only nine study patients
were shunted intraoperatively based on Columbia
University Medical Center criteria for shunting.2 No
patients were premedicated. Patients were sedated with
fentanyl and midazolam. General anesthesia was induced
with thiopental, propofol, or etomidate. Patients were
relaxed with one of the following: succinylcholine,
vecuronium, or rocuronium. Anesthesia was maintained
with muscle relaxation (vecuronium or rocuronium),
potent inhalational agent (isoﬂurane or sevoﬂurane) with
or without nitrous oxide in oxygen (2:1) as tolerated.
Standard monitors were applied, including an arterial
catheter for measuring blood pressure continuously. All
hemodynamic data plus temperature were monitored
continuously and recorded every minute by a PC-based
data acquisition system. Continuous EEG monitoring
was performed on all patients. After cross-clamping the
internal carotid artery, a signiﬁcant EEG change was
deﬁned as 50% or greater decrease in amplitude in the alpha
or beta frequencies, and a similar increase in the delta or
theta frequencies, or complete loss of all cerebral electrical
activity.
Surgery consisted of positioning the patient supine
with the head in an extended midline position. An incision
was made along a skin crease from just below the angle of
the mandible to near the midline through skin, subcuta-
neous tissue, and platysma. The common, internal, and
external carotid arteries were exposed and controlled. A
shunt was prepared and used only if changes consistent
with cerebral ischemia were noted on the EEG. After
administering heparin intravenously, the common,
internal, and external carotid arteries were occluded. A
longitudinal incision was made in the common carotid
artery proximal to the bifurcation and extended into the
internal carotid artery distal to the plaque. The atheroma
was removed using a dissector. Firmly attached intact
intima was left above and below the area of atheroma resec-
tion. A patch was inserted for procedures performed by
vascular surgeons. The neurosurgeons performed a primary
closure. Before placing the ﬁnal sutures, back-bleeding
from the common, internal, and external carotid arteries
was performed and the lumen washed with heparinized
saline. Debris and air were expelled by releasing the clip
on the superior thyroid artery, which provided inﬂow as
the ﬁnal sutures were secured. Clamps were sequentially
removed from the external, common, and internal carotid
arteries.
Neuropsychometric analysis. The outcome of cogni-
tive dysfunction was evaluated using a battery ofneuropsychometric tests preoperatively and 1 day postop-
eratively. The outcome of cognitive dysfunction is binary
(yes/no). The tests evaluate four cognitive domainsd
verbal memory (Hopkins Verbal Learning Test, Controlled
Oral Word Association Test, and/or Buschke Selective
Reminding Test), visuospatial organization (Rey-Oster-
rieth Complex Figure Copy and Recall), motor function
(Grooved Pegboard and/or Finger Tapping Test), and
executive action (Halstead-Reitan Trials A and B). The
criteria for cognitive dysfunction are based on difference
scores calculated for each test by subtracting the preoperative
test performance from the postoperative test performance
at 1 day. Similar to previous studies,25,26 a Z-score was
generated based on a surgical reference group’s performance
to account for practice effect, general anesthesia, trauma of
surgery, and the postoperative experience.
The surgical reference group is composed of 156 age-
and education-matched patients undergoing lumbar level
laminectomy or microdiscectomy #2 levels without fusion
or blood loss necessitating transfusion. The mean differ-
ence score of the reference group was subtracted from
the difference score for the CEA patient and then divided
by standard deviation (SD) of the reference group ([Differ-
ence CEA e Mean Difference Reference]/SD Reference).
Therefore, each test is evaluated in units of SD of the refer-
ence group’s change in performance. CEA patient domains
were evaluated to account for both focal and global/hemi-
spheric deﬁcits: (1) $2 SD worse performance in $2
cognitive domains or (2) $1.5 SD worse performance in
all four cognitive domains. The reference group was only
used to generate normalized Z-scores; they were not
included in any other analysis.
A variety of factors affect the risk of cognitive dysfunc-
tion after CEA. The only ones demonstrated to be signiﬁ-
cantly associated with the risk of cognitive dysfunction are
age >75, diabetes mellitus, and statin use.26-28 Other
factors that may be associated with cognitive dysfunction,
but have not been previously published to do so, were eval-
uated as well. These included sex (male/female), years of
education, body mass index, history of smoking, extensive
peripheral vascular disease, hypertension, symptomatic
history of transient ischemic attack or stroke, and duration
of cross-clamp of the carotid artery (minutes). We have
included these all of these factors in our uni- and multivar-
iate analyses.
NLR. Values from the complete blood count with
differential were obtained up to 2 weeks prior to surgery
from the hospital laboratory. Most patients had these labo-
ratory tests done as part of their routine preoperative
testing. However, only 432 of the initially enrolled 551
patients had NLR data available because complete blood
count differentials were not prospectively collected as part
of the original study protocol. The 119 patients without
NLR in the 2-week time frame either had complete
blood counts without a white blood cell differential, had
the testing done >2 weeks prior to surgery, or had the test
done at a nonafﬁliated institution. The NLR was calcu-
lated by dividing the absolute neutrophil count by the
Table I. Patients with and without neutrophil-
lymphocyte ratio (NLR) valuesa
All patients
(N ¼ 551)
With
NLR
(n ¼ 432)
Without
NLR
(n ¼ 119) Pb
Age >75 years 29.6% 28.2% 34.5% .19
Sex, male 65.0% 64.1% 68.1% .42
BMI, kg/m2 26.9 6 4.5 26.9 6 4.5 27.1 6 4.3 .76
Years of education 14.5 6 3.3 14.5 6 3.4 14.5 6 2.9 .99
History of smoking 68.4% 67.8% 70.6% .56
Statin use 60.8% 57.4% 73.1% .002
Hypertension 56.6% 53.5% 68.1% .004
Diabetes mellitus 21.1% 20.6% 22.7% .62
PVD 29.0% 28.6% 30.3% .73
Symptomatic
status
40.7% 39.4% 45.4% .24
Cross clamp
duration,
minutes
44.2 6 17.4 42.9 6 17.1 48.8 6 17.8 .002
Cognitive
dysfunction
25.8% 24.3% 31.1% .14
BMI, Body mass index; PVD, peripheral vascular disease.
aMean 6 standard deviation.
bP values of univariate comparisons of the characteristic between patients
with NLR and without NLR values.
Table II. Patient characteristics by neutrophil-
lymphocyte ratio (NLR) <5 and $5a
All patients
(N ¼ 432)
NLR < 5
(n ¼ 360)
NLR $ 5
(n ¼ 72) Pb
Age >75 years 28.2% 28.1% 29.2% .85
Sex, male 64.1% 64.7% 61.1% .56
BMI, kg/m2 26.9 6 4.5 27.2 6 4.6 25.7 6 3.5 .01
Years of
education
14.5 6 3.4 14.6 6 3.6 14.3 6 2.6 .54
History of
smoking
67.8% 69.7% 58.3% .06
Statin use 57.4% 62.8% 30.6% <.001
Hypertension 53.5% 55.3% 44.4% .09
Diabetes mellitus 20.6% 21.4% 16.7% .36
PVD 28.6% 29.0% 26.9% .73
Symptomatic
status
39.4% 38.6% 43.1% .48
Cross clamp
duration,
minutes
42.9 6 17.1 43.0 6 1.0 42.2 6 2.1 .71
NLR 3.4 6 2.9 2.4 6 1.0 8.0 6 4.6 <.001
Cognitive
dysfunction
24.3% 12.8% 34.7% <.001
BMI, Body mass index; PVD, peripheral vascular disease.
aMean 6 standard deviation.
bP values of univariate comparisons of the characteristic between patients
with NLR <5 and $5.
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Previous studies that have investigated the effect of
NLR on clinical outcomes have generally used three
methods for categorization of NLR. The ﬁrst is to treat
NLR as a continuous variable and correlate with desired
outcome. The second is using an NLR <5 or $5 as cutoff
values.16,17,29 The third is by categorizing patients into
equal tertiles on the basis of their NLR value.30-32 In this
study, we use all three methods of analysis.
Statistical analyses. Statistical analysis was performed
using JMP (SAS Institute Inc, Cary, NC). For univariate
analyses, Student t-test, Wilcoxon rank sums test, Fisher
exact test, Pearson c2 test, and simple logistic regression
were used where appropriate. A multiple logistic regression
model was constructed to identify independent predictors
of cognitive dysfunction. All factors with a P value
of <.20 in a simple univariate logistic regression were
entered into the ﬁnal model. Model ﬁt and calibration
were conﬁrmed with the likelihood ratio test, Hosmer-
Lemeshow goodness-of-ﬁt test, and receiver operating
characteristic analysis. In the event of missing values
for predictor variables, the sample mean was imputed. A
P value of # .05 was considered signiﬁcant.
RESULTS
Patient characteristics. Patient characteristics were
representative of what is expected for CEA patients
(Table I). This study evaluated both symptomatic and
asymptomatic CEA patients; of the cohort, 39.4% (n ¼
170) of patients were classiﬁed as symptomatic (Table I).
Most characteristics were similar between patients with and
without NLR values available. Patients without NLR values
available had more hypertension (68.1% vs 53.5%; P ¼
.004), statin use (73.1% vs 57.4%; P ¼ .002), and longer
cross-clamp duration (48.8 6 17.8 minutes vs 42.9 6
17.1; P ¼ .002) than patients with NLR values available
(Table I).
Patients with NLR <5 had a mean NLR of 2.4 6 1.0
while those with an NLR of $5 had a mean of 8.0 6 4.6
(Table II). Patients with an NLR <5 were similar to those
with NLR $5, with few exceptions; patients with NLR <5
had higher body mass index (27.2 6 4.6 vs 25.7 6 3.5;
P ¼ .01) and more statin use (62.8% vs 30.6%; P < .001).
Patients in the low NLR tertile had a mean NLR of
1.5 6 0.4, middle had a mean NLR of 2.6 6 0.4, and
high had a mean NLR of 6.0 6 3.8. The patient character-
istics were similar among the tertiles except for statin use
and hypertension, which slightly varied between the low,
middle, and high tertiles (Table III).
NLR and cognitive dysfunction. Of the 432
patients, 16.4% exhibited cognitive dysfunction 1 day after
CEA. Patients with cognitive dysfunction had signiﬁcantly
higher NLR levels than patients without cognitive dysfunc-
tion (4.5 6 4.0 vs 3.2 6 2.6; P < .001). Signiﬁcantly more
patients with NLR $5 had cognitive dysfunction than
patients with NLR <5 (34.7% vs 12.8%; P < .001). Signif-
icantly fewer patients in the low tertile had cognitivedysfunction than in the high tertile (6.9% vs 25.9%; P <
.001) and middle tertile (6.9% vs 17.4%; P ¼ .006).
Multivariate model. Sex, years of education, statin
use, diabetes mellitus, and NLR $5 were all included in
the ﬁnal multivariate regression model (Table IV). In the
ﬁnal model, diabetes (odds ratio [OR], 2.03; 95% conﬁ-
dence interval [CI], 1.08-3.75; P ¼ .03) and NLR $5
Table III. Patient characteristics by tertile
categorizationa
All patients
(N ¼ 432)
Low
(n ¼ 144)
Middle
(n ¼ 144)
High
(n ¼ 144)
Age >75 years 28.2% 25.0% 27.1% 32.6%
Sex, male 64.1% 63.2% 63.2% 66.0%
BMI, kg/m2 26.9 6 4.5 26.9 6 4.3 27.2 6 5.0 26.5 6 4.1
Years of
education
14.5 6 3.4 14.8 6 3.3 14.3 6 3.3 14.6 6 3.6
History of
smoking
67.8% 70.8% 66.0% 66.7%
Statin use 57.4% 66.0% 57.4% 48.6%
Hypertension 53.5% 50.7% 58.3% 51.4%
Diabetes
mellitus
20.6% 19.4% 22.9% 19.4%
PVD 28.6% 32.1% 27.0% 26.7%
Symptomatic
status
39.4% 38.2% 42.4% 37.5%
Cross clamp
duration,
minutes
42.9 6 17.1 41.5 6 16.6 43.3 6 18.1 43.7 6 16.6
NLR 3.4 6 2.9 1.5 6 0.4 2.6 6 0.4 6.0 6 3.8
Cognitive
dysfunction
16.4% 6.9% 17.4% 25.0%
BMI, Body mass index; NLR, neutrophil-lymphocyte ratio; PVD, peripheral
vascular disease.
aMean 6 standard deviation.
Table IV. Univariate and multivariate logistic regression
model
Univariate
OR (95% CI) P
Multivariate
OR (95% CI) P
Age
>75 years
1.27 (0.72-2.17) .40
Sex, male 1.48 (0.88-2.48) .14 1.16 (0.65-2.05) .61
Education,
per year
1.09 (1.01-1.18) .04 1.07 (0.98-1.17) .12
BMI,
per kg/m2
1.00 (0.95-1.06) .94
History of
smoking
1.07 (0.62-1.88) .81
Hypertension 1.07 (0.64-1.80) .79
Statin use 0.39 (0.23-0.65) <.001 0.48 (0.27-0.84) .01
Diabetes
mellitus
1.81 (1.00-3.18) .05 2.03 (1.08-3.75) .03
PVD 1.30 (0.73-2.42) .37
Symptomatic
status
0.81 (0.48-1.36) .42
Cross clamp
duration,
per minute
1.01 (0.99-1.03) .32
NLR $5 3.63 (2.03-6.43) <.001 3.38 (1.81-6.27) <.001
BMI, Body mass index; CI, conﬁdence interval; NLR, neutrophil-
lymphocyte ratio; OR, odds ratio; PVD, peripheral vascular disease.
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associated with higher odds of cognitive dysfunction, while
statin use was signiﬁcantly associated with lower odds (OR,
0.48; 95% CI, 0.27-0.84; P ¼ .01).
DISCUSSION
The NLR is easily obtainable, readily available, and
reasonably cost-effective, blood test derived from
a complete blood count differential often done as part of
preoperative testing. It is a reliable measure of systemic
inﬂammation and has been posited as a predictor of
outcomes in a variety of disciplines. However, this study
is the ﬁrst to evaluate NLR in a cohort of patients under-
going CEA and to determine whether NLR is predictive
of cognitive dysfunction. Cognitive dysfunction, though
less clinically momentous than stroke, has been associated
with markers of brain injury3 and mortality.4
The most important ﬁnding of this study is that NLR
$5 is associated with a threefold increased risk of cognitive
dysfunction 1 day after CEA. Previous studies have shown
NLR’s utility in predicting poor outcome following
surgery. Gibson et al19 found that in a cohort of patients
undergoing coronary artery bypass grafting, a high preop-
erative NLR was an independent predictor of poorer
survival. Furthermore, Duffy et al18 show that in patients
undergoing percutaneous coronary interventions, an
increased preprocedural NLR is associated with increased
risk of long-term morbidity and mortality.
The utility of NLR as a predictive tool extends beyond
cardiovascular and cerebrovascular disciplines. K Halazun
et al17 found that an elevated preoperative NLR prior toliver transplantation for hepatocellular carcinoma signiﬁ-
cantly increases its risk of recurrence. In their study, an
NLR $5 is considered to be elevated. We use the same
cutoff value and ﬁnd that an NLR $5 signiﬁcantly and
strongly predicts a poorer outcome following CEA.
Studies have observed that systemic inﬂammation is
detrimental to cognitive functioning, especially in the
operative setting.5,8,9 Importantly, the relationship
between NLR and cognitive decline has been previously
demonstrated in a small study by Kuyumcu et al; they
found that patients with Alzheimer’s disease had elevated
NLR compared with a control population.20
The mechanisms of how systemic inﬂammation and
elevated NLR result in cognitive dysfunction remain
unclear. Inﬂammation increases atherosclerotic burden
and decreases plaque stability, which may result in increased
microemboli to the brain. Furthermore, inﬂammation
increases susceptibility to neuronal injury. All these factors
place patients with elevated NLR at increase risk for cogni-
tive dysfunction following CEA.
This study also found that diabetes mellitus is also asso-
ciated with signiﬁcantly higher odds of developing cogni-
tive dysfunction. This ﬁnding is reasonable given that
diabetes is considered a chronic inﬂammatory state and
has been previously demonstrated to be a predictor of
cognitive dysfunction.27 It also found that patients taking
statins are at signiﬁcantly lower risk of cognitive dysfunc-
tion following CEA. Although we did not aim to study
this association, it is a potentially interesting relationship
that needs further investigation, as we have previously
found that statin use is associated with less cognitive
dysfunction in an asymptomatic CEA population.26
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of statins but certainly requires further prospective study.
The utility of the NLR as a measure of systemic inﬂam-
mation prior to CEA is simple, cost-effective, and, most
importantly, can provide physicians with an indicator for
cognitive dysfunction risk. Further prospective research is
necessary to determine whether NLR can be utilized as
a preoperative tool to predict and perhaps reduce the inci-
dence of cognitive dysfunction after CEA.
Limitations. We recognize several limitations of this
study. First, this was a single-center study with retrospec-
tively collected data. As a result, of the 551 patients
enrolled in our study, only 432 had NLR data available
within the prespeciﬁed time frame of 2 weeks. Further-
more, using NLR in a single preoperative blood sample
does not allow for assessing the stability of this variable
over time. Additionally, we did not collect data of other
inﬂammatory markers (ie, erythrocyte sedimentation rate
and C-reactive protein) to determine if it is an NLR speciﬁc
predictability or that of all inﬂammatory markers.
CONCLUSIONS
Preoperative NLR is independently associated with
cognitive dysfunction 1 day after CEA. NLR $5 and dia-
betes mellitus are signiﬁcantly associated with increased
risk of cognitive dysfunction. There appears to be an asso-
ciation between statin use and decreased risk of cognitive
dysfunction following CEA. Further larger prospective
trials are necessary to validate these ﬁndings and determine
if NLR can be used as a simple predictor of cognitive
dysfunction.
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